Prescription Required
Formulation: Tablet
(Brand Option)
Select the prescribed dosage
Select the quantity to see the price.
Prescription Required
Formulation: Tablet
(Generic Alternative)
Select the prescribed dosage
Select the quantity to see the price.
* This price includes a dispensing fee, medical review fee, and packing fee.
Shipped and delivered directly to your doorstep
Evista (active ingredient: raloxifene) is a prescription medication used primarily in postmenopausal women to help strengthen bones and reduce the risk of certain types of breast cancer. It belongs to a class of medications known as selective estrogen receptor modulators (SERMs).
Evista acts similarly to estrogen in some parts of the body while blocking estrogen’s effects in others. This unique action helps protect bone health without stimulating breast tissue in the same way that estrogen can.
Osteoporosis in Postmenopausal Women
Evista is used for the prevention and treatment of osteoporosis in postmenopausal women.
Osteoporosis is a condition that causes bones to become weak, thin, and more likely to break. After menopause, declining estrogen levels can accelerate bone loss and increase the risk of fractures.
Evista helps:
Maintaining healthy bones can help preserve mobility, independence, and overall quality of life as women age.
Reduction of Risk of Invasive Breast Cancer
Evista is also approved to help reduce the risk of invasive breast cancer in:
Invasive breast cancer occurs when cancer cells spread beyond the milk ducts or lobules into surrounding breast tissue.
By blocking estrogen’s effects in breast tissue, Evista may help lower the risk of developing certain hormone-sensitive breast cancers.
However, Evista is not used to treat breast cancer and is not effective against all types of breast cancer.
Evista belongs to a class of medications called selective estrogen receptor modulators (SERMs).
SERMs work by interacting with estrogen receptors throughout the body. Depending on the tissue, Evista can either mimic or block the effects of estrogen.
Effects on Bone
In bone tissue, Evista acts similarly to estrogen.
This helps:
These benefits are particularly important after menopause, when natural estrogen levels decline.
Effects on Breast Tissue
In breast tissue, Evista blocks the effects of estrogen.
Because some breast cancers rely on estrogen to grow, blocking estrogen activity may help:
When used as prescribed, Evista may help:
Evista is available as an oral tablet that is typically taken once daily, with or without food, as directed by your healthcare provider.
To help ensure the medication works effectively, take Evista at the same time each day. Establishing a regular routine can make it easier to remember your daily dose and maintain consistent medication levels in your body.
Swallow the tablet whole with water. Do not crush, chew, or break the tablet, as it has a bitter taste and should be taken exactly as prescribed.
For most postmenopausal women, the recommended dose of Evista is:
The tablet may be taken at any time of the day and does not need to be taken with meals.
To help support bone health while taking Evista, your healthcare provider may also recommend adequate intake of:
Taking a higher dose than prescribed will not improve treatment effectiveness and may increase the risk of side effects.
Evista works best when combined with healthy lifestyle habits that support bone health, including:
Because osteoporosis often develops without noticeable symptoms, continue taking Evista even if you feel well, unless your healthcare provider advises otherwise.
Regular medical follow-up and bone density testing may be recommended to monitor your response to treatment and help ensure long-term bone health.
Evista (Raloxifene) is available in the following forms and strength:
Before taking Evista, discuss your medical history and any existing health conditions with your healthcare provider. Certain conditions may increase the risk of serious complications and may make Evista unsuitable for some individuals.
Evista can increase the risk of developing blood clots, which can be serious and potentially life-threatening.
You should not take Evista if you have a current or previous history of:
If you have ever experienced a blood clot, inform your healthcare provider before starting treatment.
Seek immediate medical attention if you develop symptoms such as:
Evista may increase the risk of stroke, including strokes that can be fatal in certain individuals.
The risk may be higher in women who have:
Before starting Evista, discuss your cardiovascular risk factors with your healthcare provider to determine whether this medication is appropriate for you.
Seek emergency medical attention if you experience signs of a stroke, such as:
Evista is intended for use only in postmenopausal women.
Do not take Evista if you are:
Raloxifene may harm an unborn baby and is not recommended during pregnancy or while nursing.
Inform your healthcare provider immediately if you become pregnant while taking this medication.
Periods of reduced movement can increase the risk of blood clots while taking Evista.
If you are planning:
Your healthcare provider may recommend stopping Evista at least 3 days before the period of immobility.
You may need to wait until you are fully active again before restarting treatment.
Always inform your surgeon, physician, or other healthcare providers that you are taking Evista.
Contact your healthcare provider immediately if you experience:
Regular follow-up appointments can help ensure that Evista remains a safe and effective treatment for osteoporosis prevention and breast cancer risk reduction.
Evista works by binding to estrogen receptors in different tissues throughout the body. It acts like estrogen in some areas, such as the bones, while blocking estrogen’s effects in other tissues, including the breast. This unique action helps maintain and improve bone strength, slow bone loss after menopause, increase bone mineral density, reduce the risk of vertebral fractures, and lower the risk of invasive breast cancer in certain postmenopausal women. Because Evista selectively mimics and blocks estrogen’s effects, it can provide some of estrogen’s beneficial effects on bone health without affecting all tissues in the same way.
The recommended dosage of Evista is one 60 mg tablet taken once daily. The tablet may be taken at any time of day and can be taken with or without food. To help maintain consistent medication levels and improve adherence, it is recommended to take Evista at the same time each day. Always take the medication exactly as prescribed by your healthcare provider, and do not change your dose or stop treatment without consulting them first.
Yes. Evista has been approved by the U.S. Food and Drug Administration (FDA) for long-term use in appropriate patients and is commonly prescribed for the ongoing prevention and treatment of osteoporosis in postmenopausal women. It is also used long-term in certain postmenopausal women who are at increased risk of developing invasive breast cancer. As with any medication, the benefits and potential risks of long-term treatment should be reviewed regularly with your healthcare provider. Factors such as your medical history, risk of fractures, risk of blood clots, and overall health will help determine whether continued treatment with Evista remains appropriate for your individual situation. Regular follow-up appointments can help ensure that Evista continues to be a safe and effective part of your long-term treatment plan.
| Generic name: | Raloxifene |
|---|---|
| Formulation: | Tablet |
| Strength(s): | 60mg |
| Quantities Available: | 84 |
Our online Canadian Pharmacy is known for high standards of quality, safety, and efficiency when it comes to medications.
Our pharmacy offers lower prices on prescription drugs compared to traditional pharmacies.
When ordering Evista (raloxifene) from a Canadian pharmacy, you can typically purchase up to a 90-day supply at one time, which is common for prescription medications to ensure adequate management of chronic conditions without frequent refills.
Here’s what you need to know:
Dosage and Quantity: Evista is commonly prescribed in a dosage of 60 mg once daily. For a 90-day supply, this means you would order 90 tablets (90 days x 1 tablet per day).
Yes, we sell raloxifene. You can enjoy low prices when you order from us. To dispense the medication, you will need a valid prescription from your healthcare provider. We require this to ensure your safety and proper medication management. You can mail, fax, or upload your prescription through your online account.
Yes, we ship Evista (raloxifene) to both the United States and Puerto Rico.
Watch how Online Pharmacies Canada is helping customers save money on their medications.
Online Pharmacies Canada has provided information from third parties intended to increase awareness and does not contain all the information about Evista (Raloxifene). Talk to your doctor or other qualified medical practitioners for medical attention or advice, or if you have any concerns about Evista (Raloxifene).
REVIEWS